Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Cannabis Policy Wire
CED Clinical Relevanceย ย #76Notable Clinical Interestย ย Emerging findings or policy developments worth monitoring closely.
๐Ÿงช Clinical Trial Watchย ย |ย ย CED Clinic
Clinical TrialCbdNeuropathyCancerNeuroprotection
Trial ID NCT07167446
Phase N/A
Status Recruiting
Condition Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
Intervention Cannabidiol (CBD)
Why This Matters

Oxaliplatin-induced peripheral neuropathy affects up to 90% of patients receiving this standard colorectal cancer chemotherapy, often forcing dose reductions or treatment discontinuation. Current preventive strategies remain inadequate, creating an urgent need for effective neuroprotective interventions that don’t compromise oncologic outcomes.

Clinical Summary

This pilot randomized controlled trial is evaluating hemp-derived CBD supplementation as a preventive strategy against oxaliplatin-induced peripheral neuropathy in colorectal cancer patients. The study compares CBD capsules plus standard care versus standard care alone, with primary endpoints focused on feasibility and acceptability of CBD integration into oncology treatment protocols. The trial is currently recruiting participants and represents an important step toward understanding CBD’s potential role in chemotherapy-induced neuropathy prevention.

Dr. Caplan’s Take

โ€œIf this pilot demonstrates feasibility and early efficacy signals, it could establish the foundation for larger definitive trials examining CBD’s neuroprotective potential in cancer care. This represents exactly the type of rigorous, condition-specific research needed to advance evidence-based cannabis medicine in oncology supportive care.โ€

Clinical Perspective
๐Ÿง  Patients considering participation should discuss potential drug interactions between CBD and chemotherapy agents with their oncology team, as CBD can affect certain drug metabolizing enzymes. Clinicians should monitor for any changes in oxaliplatin efficacy or toxicity profiles, while recognizing this pilot’s primary goal is establishing research feasibility rather than definitive therapeutic outcomes.

๐Ÿ’ฌ Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan โ†’

Want to discuss this topic with other patients and caregivers? Join the forum discussion โ†’

 






{“@context”: “https://schema.org”, “@type”: “MedicalStudy”, “headline”: “Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy”, “url”: “https://clinicaltrials.gov/study/NCT07167446”, “about”: “n oxaliplatin induced peripheral neuropathy cancer”}


, ,